Table 3.

Adverse Event Values

Parameter	Value	Data Source
Adverse Event Rates for EPS
Olanzapine	15.5%	Carlson et al., 2003 [67]
Risperidone	24.7%
Quetiapine	8.0%	Package insert, revised 10/2007
Ziprasidone	14.0%	Package insert, revised 07/2007
Aripiprazole	21.0%	Fleischhacker et al., 2008 [68]
Adverse Event Rates for Clinically Significant Weight Gain (≥ 7%)
Olanzapine	30.0%
Risperidone	14.0%	Lieberman et al., 2005 [23]
Quetiapine	16.0%
Ziprasidone	7.0%
Aripiprazole	7.3%	Fleischhacker et al., 2008 [68]
Adverse Event Rates for Diabetes
Olanzapine	3.3%
Risperidone	3.2%	Lambert et al., 2006 [69]
Quetiapine	3.6%
Ziprasidone	2.0%	Assumed equal to Lambert et al., 2006 [69] lowest reported rate, that for typicals
Aripiprazole	2.0%
Adverse Event Rates for Hyperlipidemia
Olanzapine	16.8%
Risperidone	14.0%	Lieberman et al., 2005 [23]
Quetiapine	14.1%	Lambert et al., 2005 [70]
Ziprasidone	8.1%	Olfson et al., 2006 [71]
Aripiprazole	3.6%